Week in review: COVID again, FDA approvals, VEGF alternative
- Posted on: Oct 30 2020
- Leave a response
This week, clinicians report another possible ocular manifestation of COVID-19, the FDA approves new drugs for dry eye and pediatric vernal keratoconjuncitivitis, and researchers propose a new mechanism to treat retinal diseases.
Source: AAO
Posted in: Uncategorized